840 related articles for article (PubMed ID: 27059145)
1. Autoantibody-Positive Healthy Individuals Display Unique Immune Profiles That May Regulate Autoimmunity.
Slight-Webb S; Lu R; Ritterhouse LL; Munroe ME; Maecker HT; Fathman CG; Utz PJ; Merrill JT; Guthridge JM; James JA
Arthritis Rheumatol; 2016 Oct; 68(10):2492-502. PubMed ID: 27059145
[TBL] [Abstract][Full Text] [Related]
2. Dysregulation of innate and adaptive serum mediators precedes systemic lupus erythematosus classification and improves prognostic accuracy of autoantibodies.
Lu R; Munroe ME; Guthridge JM; Bean KM; Fife DA; Chen H; Slight-Webb SR; Keith MP; Harley JB; James JA
J Autoimmun; 2016 Nov; 74():182-193. PubMed ID: 27338520
[TBL] [Abstract][Full Text] [Related]
3. Elevated STAT1 expression but not phosphorylation in lupus B cells correlates with disease activity and increased plasmablast susceptibility.
Aue A; Szelinski F; Weißenberg SY; Wiedemann A; Rose T; Lino AC; Dörner T
Rheumatology (Oxford); 2020 Nov; 59(11):3435-3442. PubMed ID: 32357246
[TBL] [Abstract][Full Text] [Related]
4. Autoimmune response of IgE antibodies to cellular self-antigens in systemic Lupus Erythematosus.
Atta AM; Santiago MB; Guerra FG; Pereira MM; Sousa Atta ML
Int Arch Allergy Immunol; 2010; 152(4):401-6. PubMed ID: 20197682
[TBL] [Abstract][Full Text] [Related]
5. BAFF-R and TACI expression on CD3+ T cells: Interplay among BAFF, APRIL and T helper cytokines profile in systemic lupus erythematosus.
Salazar-Camarena DC; Ortíz-Lazareno P; Marín-Rosales M; Cruz A; Muñoz-Valle F; Tapia-Llanos R; Orozco-Barocio G; Machado-Contreras R; Palafox-Sánchez CA
Cytokine; 2019 Feb; 114():115-127. PubMed ID: 30467093
[TBL] [Abstract][Full Text] [Related]
6. Autoantibody-positive healthy individuals with lower lupus risk display a unique immune endotype.
Slight-Webb S; Smith M; Bylinska A; Macwana S; Guthridge C; Lu R; Merrill JT; Chakravarty E; Arriens C; Munroe ME; Maecker HT; Utz PJ; Guthridge JM; James JA
J Allergy Clin Immunol; 2020 Dec; 146(6):1419-1433. PubMed ID: 32446964
[TBL] [Abstract][Full Text] [Related]
7. Interferon-α-induced B-lymphocyte stimulator expression and mobilization in healthy and systemic lupus erthymatosus monocytes.
López P; Scheel-Toellner D; Rodríguez-Carrio J; Caminal-Montero L; Gordon C; Suárez A
Rheumatology (Oxford); 2014 Dec; 53(12):2249-58. PubMed ID: 24942493
[TBL] [Abstract][Full Text] [Related]
8. Anti-ribosomal P antibodies are associated with elevated circulating IFNα and IL-10 levels in systemic lupus erythematosus patients.
Mozo L; López P; Caminal-Montero L; Rodríguez-Carrio J; Suárez A
Lupus; 2014 Dec; 23(14):1477-85. PubMed ID: 25107939
[TBL] [Abstract][Full Text] [Related]
9. Patterns of ANA+ B cells for SLE patient stratification.
Suurmond J; Atisha-Fregoso Y; Barlev AN; Calderon SA; Mackay MC; Aranow C; Diamond B
JCI Insight; 2019 May; 4(9):. PubMed ID: 31045579
[TBL] [Abstract][Full Text] [Related]
10. Neutrophil Extracellular Trap Mitochondrial DNA and Its Autoantibody in Systemic Lupus Erythematosus and a Proof-of-Concept Trial of Metformin.
Wang H; Li T; Chen S; Gu Y; Ye S
Arthritis Rheumatol; 2015 Dec; 67(12):3190-200. PubMed ID: 26245802
[TBL] [Abstract][Full Text] [Related]
11. B cell autophagy mediates TLR7-dependent autoimmunity and inflammation.
Weindel CG; Richey LJ; Bolland S; Mehta AJ; Kearney JF; Huber BT
Autophagy; 2015; 11(7):1010-24. PubMed ID: 26120731
[TBL] [Abstract][Full Text] [Related]
12. Low CD4 + T cell count is related to specific anti-nuclear antibodies, IFNα protein positivity and disease activity in systemic lupus erythematosus pregnancy.
Torell A; Stockfelt M; Blennow K; Zetterberg H; Akhter T; Leonard D; Rönnblom L; Pihl S; Saleh M; Sjöwall C; Strevens H; Jönsen A; Bengtsson AA; Trysberg E; Majczuk Sennström M; Zickert A; Svenungsson E; Gunnarsson I; Bylund J; Jacobsson B; Rudin A; Lundell AC
Arthritis Res Ther; 2024 Mar; 26(1):65. PubMed ID: 38459582
[TBL] [Abstract][Full Text] [Related]
13. Characterization of ribosomal P autoantibodies in relation to cell destruction and autoimmune disease.
Ersvaer E; Bertelsen LT; Espenes LC; Bredholt T; Bøe SO; Iversen BM; Bruserud Ø; Ulvestad E; Gjertsen BT
Scand J Immunol; 2004; 60(1-2):189-98. PubMed ID: 15238089
[TBL] [Abstract][Full Text] [Related]
14. Prediction of autoimmune connective tissue disease in an at-risk cohort: prognostic value of a novel two-score system for interferon status.
Md Yusof MY; Psarras A; El-Sherbiny YM; Hensor EMA; Dutton K; Ul-Hassan S; Zayat AS; Shalbaf M; Alase A; Wittmann M; Emery P; Vital EM
Ann Rheum Dis; 2018 Oct; 77(10):1432-1439. PubMed ID: 29929956
[TBL] [Abstract][Full Text] [Related]
15. T-regs in autoimmune hepatitis-systemic lupus erythematosus/mixed connective tissue disease overlap syndrome are functionally defective and display a Th1 cytokine profile.
Longhi MS; Ma Y; Grant CR; Samyn M; Gordon P; Mieli-Vergani G; Vergani D
J Autoimmun; 2013 Mar; 41():146-51. PubMed ID: 23287048
[TBL] [Abstract][Full Text] [Related]
16. Plasmablasts With a Mucosal Phenotype Contribute to Plasmacytosis in Systemic Lupus Erythematosus.
Mei HE; Hahne S; Redlin A; Hoyer BF; Wu K; Baganz L; Lisney AR; Alexander T; Rudolph B; Dörner T
Arthritis Rheumatol; 2017 Oct; 69(10):2018-2028. PubMed ID: 28622453
[TBL] [Abstract][Full Text] [Related]
17. Comparison of autoantibody specificities between traditional and bead-based assays in a large, diverse collection of patients with systemic lupus erythematosus and family members.
Bruner BF; Guthridge JM; Lu R; Vidal G; Kelly JA; Robertson JM; Kamen DL; Gilkeson GS; Neas BR; Reichlin M; Scofield RH; Harley JB; James JA
Arthritis Rheum; 2012 Nov; 64(11):3677-86. PubMed ID: 23112091
[TBL] [Abstract][Full Text] [Related]
18. Anti-ribosomal P protein antibody in human systemic lupus erythematosus up-regulates the expression of proinflammatory cytokines by human peripheral blood monocytes.
Nagai T; Arinuma Y; Yanagida T; Yamamoto K; Hirohata S
Arthritis Rheum; 2005 Mar; 52(3):847-55. PubMed ID: 15751081
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D deficiency is associated with an increased autoimmune response in healthy individuals and in patients with systemic lupus erythematosus.
Ritterhouse LL; Crowe SR; Niewold TB; Kamen DL; Macwana SR; Roberts VC; Dedeke AB; Harley JB; Scofield RH; Guthridge JM; James JA
Ann Rheum Dis; 2011 Sep; 70(9):1569-74. PubMed ID: 21586442
[TBL] [Abstract][Full Text] [Related]
20. Neutralization of interferon-alpha/beta-inducible genes and downstream effect in a phase I trial of an anti-interferon-alpha monoclonal antibody in systemic lupus erythematosus.
Yao Y; Richman L; Higgs BW; Morehouse CA; de los Reyes M; Brohawn P; Zhang J; White B; Coyle AJ; Kiener PA; Jallal B
Arthritis Rheum; 2009 Jun; 60(6):1785-96. PubMed ID: 19479852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
